Yonsei Med J.  2017 May;58(3):679-681. 10.3349/ymj.2017.58.3.679.

Bortezomib-Containing Multimodality Treatment for Antibody-Mediated Rejection with Anti-HLA and Anti-AT1R Antibodies after Kidney Transplantation

• Iesari S
• Lai Q
• Favi E
• Pisani F

• KMID: 2419133
• DOI: http://doi.org/10.3349/ymj.2017.58.3.679

Abstract

No abstract available.

Reference

1. Lee J, Kim BS, Park Y, Lee JG, Lim BJ, Jeong HJ, et al. The effect of bortezomib on antibody-mediated rejection after kidney transplantation. Yonsei Med J. 2015; 56:1638–1642.

2. Walsh RC, Alloway RR, Girnita AL, Woodle ES. Proteasome inhibitor-based therapy for antibody-mediated rejection. Kidney Int. 2012; 81:1067–1074.

3. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant. 2004; 4:378–383.

4. Banasik M, Boratyn´ska M, Kos´cielska-Kasprzak K, Mazanowska O, Bartoszek D, Zabin´ska M, et al. Long-term follow-up of non-HLA and anti-HLA antibodies: incidence and importance in renal transplantation. Transplant Proc. 2013; 45:1462–1465.

5. Reinsmoen NL, Lai CH, Heidecke H, Haas M, Cao K, Ong G, et al. Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients. Transplantation. 2010; 90:1473–1477.

6. Reinsmoen NL. Role of angiotensin II type 1 receptor-activating antibodies in solid organ transplantation. Hum Immunol. 2013; 74:1474–1477.

7. Giral M, Foucher Y, Dufay A, Van Huyen JP, Renaudin K, Moreau A, et al. Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss. Am J Transplant. 2013; 13:2567–2576.

8. Gupta G, Abu Jawdeh BG, Racusen LC, Bhasin B, Arend LJ, Trollinger B, et al. Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies. Transplantation. 2014; 97:1240–1246.

9. Djamali A, Kaufman DB, Ellis TM, Zhong W, Matas A, Samaniego M. Diagnosis and management of antibody-mediated rejection: current status and novel approaches. Am J Transplant. 2014; 14:255–271.

10. Kranz B, Kelsch R, Kuwertz-Bröking E, Bröcker V, Wolters HH, Konrad M. Acute antibody-mediated rejection in paediatric renal transplant recipients. Pediatr Nephrol. 2011; 26:1149–1156.